3TR – Taxonomy, Treatment, Targets and Remission

3TR aims to provide fundamental new insights into the mechanisms of response and non-response to treatment. Thereby, they challenge the conventional “single disease”-based approach, in which diseases are classified according to their end-organ involvement rather than the molecular pathways underpinning them. They propose a paradigm shift in the way we look at diseases: Promoting a scientific evidence-based rationale for treatment selection, rather than following the traditional trial and error approach, 3TR will have significant implications for future patient management and the assessment of efficacy, safety and quality of future health products.

• Researcher: José Antonio García Salcedo
• Group: E16-MICROBIOLOGIA EMERGENTE Y TRASLACIONAL
• Center: Instituto de Investigación Biosanitaria ibs.GRANADA / University Hospital Virgen de las Nieves
• Rol in the project: Partner
• Duration: 2019 – 2026

Página web del proyecto: https://3tr-imi.eu/